[1]
Hussain, S.A., Faisal, H. and Dy, G.K. 2024. Prolonged disease control despite ALK inhibitor discontinuation in advanced ALK-positive NSCLC. European Journal of Case Reports in Internal Medicine. 11, (Apr. 2024). DOI:https://doi.org/10.12890/2024_004527.